Literature DB >> 2917150

Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat.

E Fernandez1, B Borgström.   

Abstract

Tetrahydrolipstatin (THL) derived by hydrogenation from lipstatin, a lipase inhibitor produced by Streptomyces toxytricini, has been shown to inhibit in vitro the activity of all three lipases secreted to the gastro-intestinal tract; gastric lipase, pancreatic lipase and carboxylester lipase (cholesterol ester hydrolase). The effects of THL on intestinal absorption of fat (transport to the thoracic duct chyle) has now been investigated after intraduodenal infusion in a rat model. Absorption of label from oleic acid when administered with monoolein in micellar bile salt solution was not affected by THL in concentrations up to 10(-4) M calculated on the volume of the aqueous phase. Absorption of free cholesterol in micellar bile salt solution of the lipolytic products of triolein; oleic acid and monoolein, is not significantly affected at a concentration of THL of 10(-4) M. Absorption of cholesterol from cholesteryl oleate under the same conditions is almost completely inhibited. The results indicate that absorption of free cholesterol is not dependent on the activity of pancreatic cholesterol ester hydrolase. The absorption of emulsified triolein was not significantly affected by 10(-5) M THL but decreased to around 30% of the controls by a concentration 10-times higher. There was no significant decrease of cholesterol absorption when administered in emulsified triolein while absorption of cholesteryl oleate was reduced at both concentrations of THL and almost completely at 10(-4) M. Radioactivity from [2-14C]THL when administered emulsified in triolein was recovered in urine, bile and thoracic duct lymph to 10-14, 8-13 and 1-3%, respectively, largely independent on dose administered. Label from [1"-14C] THL was recovered in the same amounts in lymph but much less in bile and urine indicating that the amino acid moiety has been split off early in the absorption process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917150     DOI: 10.1016/0005-2760(89)90107-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor.

Authors:  J Borovicka; W Schwizer; G Guttmann; D Hartmann; M Kosinski; C Wastiel; A Bischof-Delaloye; M Fried
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.

Authors:  F Froehlich; D Hartmann; C Guezelhan; J J Gonvers; J B Jansen; M Fried
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).

Authors:  Maria Høtoft Michaelsen; Kishor M Wasan; Olena Sivak; Anette Müllertz; Thomas Rades
Journal:  AAPS J       Date:  2016-01       Impact factor: 4.009

4.  Pancreatic lipase/colipase-mediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells.

Authors:  S C Young; D Y Hui
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

5.  Screening of lipase inhibitors from marine algae.

Authors:  N Bitou; M Ninomiya; T Tsujita; H Okuda
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

6.  Intestinal absorption of retinol and retinyl palmitate in the rat. Effects of tetrahydrolipstatin.

Authors:  E Fernández; B Borgström
Journal:  Lipids       Date:  1990-09       Impact factor: 1.880

7.  Effect of orlistat on fat absorption in rats: a comparison of normal rats and rats with diverted bile and pancreatic juice.

Authors:  Trine Porsgaard; Ellen Marie Straarup; Huiling Mu; Carl-Erik Høy
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

8.  Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.

Authors:  Anton I Rosenbaum; Madalina Rujoi; Amy Y Huang; Hong Du; Gregory A Grabowski; Frederick R Maxfield
Journal:  Biochim Biophys Acta       Date:  2009-08-20

9.  Carboxyl ester lipase deficiency exacerbates dietary lipid absorption abnormalities and resistance to diet-induced obesity in pancreatic triglyceride lipase knockout mice.

Authors:  Dean Gilham; Eric D Labonté; Juan C Rojas; Ronald J Jandacek; Philip N Howles; David Y Hui
Journal:  J Biol Chem       Date:  2007-06-29       Impact factor: 5.157

10.  The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.

Authors:  Sonia A Tucci; Emma J Boyland; Jason Cg Halford
Journal:  Diabetes Metab Syndr Obes       Date:  2010-05-10       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.